Dimpel, R.; Novotny, A.; Slotta-Huspenina, J.; Langer, R.; Friess, H.; Reim, D.
UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer. Cancers 2022, 14, 6169.
https://doi.org/10.3390/cancers14246169
AMA Style
Dimpel R, Novotny A, Slotta-Huspenina J, Langer R, Friess H, Reim D.
UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer. Cancers. 2022; 14(24):6169.
https://doi.org/10.3390/cancers14246169
Chicago/Turabian Style
Dimpel, Rebekka, Alexander Novotny, Julia Slotta-Huspenina, Rupert Langer, Helmut Friess, and Daniel Reim.
2022. "UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer" Cancers 14, no. 24: 6169.
https://doi.org/10.3390/cancers14246169
APA Style
Dimpel, R., Novotny, A., Slotta-Huspenina, J., Langer, R., Friess, H., & Reim, D.
(2022). UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer. Cancers, 14(24), 6169.
https://doi.org/10.3390/cancers14246169